Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Dec 09, 2024

SELL
$191.89 - $259.92 $16.7 Million - $22.6 Million
-86,900 Closed
0 $0
Q4 2022

Dec 09, 2024

BUY
$197.11 - $250.07 $17.1 Million - $21.7 Million
86,900 New
86,900 $18.9 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.